(주)젬크로 logo — 신약개발을 위한 유전자변형 질환모델동물 개발 전문기업

(주)젬크로

신약개발을 위한 유전자변형 질환모델동물 개발 전문기업

Founded 2021 Korea South Korea South 1 employees Venture round Biotechnology, Pharmaceutical

General Information

Company Name (주)젬크로
Founded Year 2021
Location Korea South Korea South
Employees 1
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with (주)젬크로. To contact (주)젬크로, visit gemcro.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About (주)젬크로

(주)젬크로 is a biotechnology startup based in Korea South, founded in 2021. Their slogan, "신약개발을 위한 유전자변형 질환모델동물 개발 전문기업," translates to "Specialized company for developing genetically modified disease model animals for new drug development." 젬크로 specializes in developing and supplying CRISPR/Cas9 technology-based genetically modified mice (GEM). The company aims to provide GEM platforms required for new drug development and efficacy evaluation while targeting new anticancer drug development. They received a Venture Round investment on 01 January 2023 from Union Investment Partners.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Union Investment Partners
01 Jan 2023

FAQ About (주)젬크로

신약개발을 위한 유전자변형 질환모델동물 개발 전문기업
(주)젬크로 was founded in 2021.
(주)젬크로 is headquartered in Korea South.
(주)젬크로 operates in Biotechnology and Pharmaceutical.
(주)젬크로 has approximately 1 employees.
(주)젬크로 has completed 1 funding round. The latest funding stage is Venture round.

We're actively collecting intelligence on (주)젬크로.

Source: BounceWatch company record for (주)젬크로, https://bouncewatch.com/company/-1481, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes